A Day Up For Climb Bio, Inc.
Mon, Dec 15, 2025 at 07:41 PM
Climb Bio, Inc. (CLYM:NASDAQ) jumped higher at $3.81, representing a gain of 27%. On Mon, Dec 15, 2025, CLYM:NASDAQ touched a New 2-Week High of $3.81. The stock got featured on our News Catalysts scanner on Tue, Nov 25, 2025 at 09:08 AM in the 'PRIVATE PLACEMENT' category. From Tue, Dec 02, 2025, the stock recorded 77.78% Up Days and 70.00% Green Days
The stock spiked on Mon, Dec 15, 2025 at $4.82 with a volume of 22M+.
About Climb Bio, Inc. (CLYM:NASDAQ)
Eliem Therapeutics Inc is a clinical-stage biotechnology company.
Top 10 Gainers:
- Radiopharm Theranostics Limited (RADX:NASDAQ), 149.53%
- Artiva Biotherapeutics, Inc. (ARTV:NASDAQ), 90.91%
- NetClass Technology Inc (NTCL:NASDAQ), 39.71%
- 3 E Network Technology Group Limited (MASK:NASDAQ), 36.35%
- Quipt Home Medical Corp. (QIPT:NASDAQ), 34.1%
- Kaixin Holdings (KXIN:NASDAQ), 33.73%
- AlphaVest Acquisition Corp (ATMV:NASDAQ), 31.3%
- Climb Bio, Inc. (CLYM:NASDAQ), 27%
- Click Holdings Limited (CLIK:NASDAQ), 26.32%
- Fenbo Holdings Limited (FEBO:NASDAQ), 23.26%